How does Rosuvastatin influence lipid markers in patients with hepatic steatosis, and what are the implications for reducing cardiovascular risks?
Sahil KapoorExplorer
How does Rosuvastatin influence lipid markers in patients with hepatic steatosis?
Share
Rosuvastatin effectively lowers LDL-C and total cholesterol, which can help mitigate cardiovascular risks in hepatic steatosis patients by improving lipid profiles.